124 related articles for article (PubMed ID: 1284814)
1. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
Haidar M; Seddiki N; Gluckman JC; Gattegno L
Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
[TBL] [Abstract][Full Text] [Related]
2. Mannosyl/N-acetyl-beta-D-glucosaminyl binding properties of the envelope glycoprotein of human immunodeficiency virus type 2.
Haïdar M; Gluckman JC; Gattegno L
Glycobiology; 1992 Oct; 2(5):429-35. PubMed ID: 1281021
[TBL] [Abstract][Full Text] [Related]
3. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.
Rabehi L; Ferriere F; Saffar L; Gattegno L
Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416
[TBL] [Abstract][Full Text] [Related]
4. Interactions of HIV-1 and HIV-2 envelope glycoproteins with sulphated polysaccharides and mannose-6-phosphate.
Mbemba E; Gluckman JC; Gattegno L
Glycobiology; 1994 Feb; 4(1):13-21. PubMed ID: 8186546
[TBL] [Abstract][Full Text] [Related]
5. The interaction of a glycosaminoglycan, heparin, with HIV-1 major envelope glycoprotein.
Mbemba E; Czyrski JA; Gattegno L
Biochim Biophys Acta; 1992 Dec; 1180(2):123-9. PubMed ID: 1281430
[TBL] [Abstract][Full Text] [Related]
6. N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1.
Gattegno L; Sadeghi H; Saffar L; Bladier D; Clerget-Raslain B; Gluckman JC; Bahraoui E
Carbohydr Res; 1991 Jun; 213():79-93. PubMed ID: 1682045
[TBL] [Abstract][Full Text] [Related]
7. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
[TBL] [Abstract][Full Text] [Related]
8. Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate.
Mbemba E; Chams V; Gluckman JC; Klatzmann D; Gattegno L
Biochim Biophys Acta; 1992 Jan; 1138(1):62-7. PubMed ID: 1371075
[TBL] [Abstract][Full Text] [Related]
9. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
Fenouillet E; Gluckman JC
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
[TBL] [Abstract][Full Text] [Related]
10. The role of calcium and N-linked glycans in the oligomerization and carbohydrate binding properties of human immunodeficiency virus external envelope glycoprotein.
Haidar M; Seddiki N; Gluckman JC; Gattegno L
Glycoconj J; 1994 Apr; 11(2):73-9. PubMed ID: 7804009
[TBL] [Abstract][Full Text] [Related]
11. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.
Seddiki N; Rabehi L; Benjouad A; Saffar L; Ferriere F; Gluckman JC; Gattegno L
Glycobiology; 1997 Dec; 7(8):1229-36. PubMed ID: 9455924
[TBL] [Abstract][Full Text] [Related]
12. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
[TBL] [Abstract][Full Text] [Related]
13. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4.
Andersen O; Sørensen AM; Svehag SE; Fenouillet E
Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
Su H; Boackle RJ
Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.
Mbemba E; Carré V; Atemezem A; Saffar L; Gluckman JC; Gattegno L
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):47-53. PubMed ID: 8825618
[TBL] [Abstract][Full Text] [Related]
16. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
Fenouillet E; Miquelis R; Drillien R
Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
[TBL] [Abstract][Full Text] [Related]
17. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.
Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.
Gorse GJ; Frey SE; Patel G; Newman FK; Belshe RB
Vaccine; 1994 Aug; 12(10):912-8. PubMed ID: 7975833
[TBL] [Abstract][Full Text] [Related]
19. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the HIV-1 external envelope glycoprotein 120 (gp120) C2 region in gp120 oligomerization.
Seddiki N; Bouhlal H; Rabehi L; Benjouad A; Devaux C; Gluckman JC; Gattegno L
Biochim Biophys Acta; 1997 Jul; 1340(2):277-82. PubMed ID: 9252114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
